Bentham Science Publishers is pleased to announce
that MicroRNA
has been awarded an Impact Factor ranking by Clarivate Analytics. The journal, currently
edited by Dr. Alberto Izzoti (University of Genoa), has been providing readers
with cutting-edge research on molecular biology and the therapeutic
applications of MicroRNAs. Bentham Science extends its heartfelt congratulations
to all journal contributors, including editors, authors and staff who have
supported the journal since its inception.
Impact Factor Update: With
MicroRNA’s addition to the Impact Factor list, 62 Bentham
Science journals now hold this prestigious distinction. Current
Neuropharmacology continues to lead the list with a 2024 impact factor of
5.3, followed by Recent Patents on Anti-Cancer Drug Discovery
(4.1) and Current Medicinal Chemistry (3.5). Bentham Science is
committed to publishing impactful research in the years to come.
About Bentham Science Publishers: Bentham
Science Publishers is a leading academic publisher that specializes in medical
and general STM (Science, Technology, and Medicine) disciplines. With a diverse
portfolio of over 130 hybrid and Open Access journals, Bentham Science is
dedicated to disseminating high-quality research to the global scientific
community. Founded in 1992, Bentham Science was established "by scientists
for scientists" and has maintained an unwavering commitment to excellence.
Its peer review process is among the most rigorous in the industry, with all
manuscripts undergoing double blind review by a verified pool of experts.
For media inquiries, please contact: [email protected]
Bentham Science Publishers sincerely thanks all those who have
contributed to its mission of advancing scientific knowledge while upholding
the highest standards of integrity and scholarly excellence.
Updated list of Bentham Science Journals with Impact Factors:
